Diabetes Relief: Major Manufacturers Cap Insulin Prices at $35, Answering Calls for Affordability in the US Novo Nordisk, Sanofi, and Eli Lily are working together to make insulin less costly for millions of people in the US suffering from diabetes. by Quincy Jon
Health COVID-19 Vaccine: Sanofi, GSK Seeks Authorization, Says Immunization Shot is More Effective Against Severe Disease by Isaiah Richard
Health Pharma Giant and COVID-19 Vaccine Front-Runner Charged With Manslaughter Over Birth Defects by Nhx T.
Health Experts Warn Dengue Vaccine Can Make People Sick: Here's What You Should Know by Saranya Palanisamy
Healthy Living/Wellness FDA Approves Eli Lilly's Drug Basaglar For Diabetes Treatment by Katrina Pascual
Healthy Living/Wellness Sanofi Issues Voluntary Recall Of Epinephrine Injectors For Severe Allergy by Katherine Derla
Healthy Living/Wellness Express Scripts Allots 750 Million To Cover Amgen And Sanofi Cholesterol Drugs by Rina Marie Doctor
Healthy Living/Wellness Regeneron And Sanofi Announce EU Approval For Anti-Cholesterol Drug Praluent by Dianne Depra
Business Tech Google Teams Up With Sanofi To Improve Diabetes Management And Treatment by Lauren Keating
Healthy Living/Wellness Sanofi Partners With Apeiron And Evotec To Develop Drug For Blood Cancers And Solid Tumors by Ted Ranosa
Healthy Living/Wellness Sanofi, Regeneron experimental drug lowers risk of stroke, heart attack by Dianne Depra
Healthy Living/Wellness FDA requests investigation of cholesterol drug's neurocognitive risks by Tabitha Laffernis